Citations

Clear

30 citation(s) found for "Ripoll, Juan G".

Response to the Letter to the Editor: Obesity and Mortality in V-V ECMO: Patient Heterogeneity Explains the Conflicting Findings
Ripoll, Juan G

Mayo Clinic

ASAIO Journal | October 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/mat.0000000000002890 | PMID 42881511 Get It

Response to Letter to the Editor: Directional Bias and the Obesity Paradox in Venovenous ECMO
Morales Behaine, Juan J , Ripoll, Juan G

Mayo Clinic

ASAIO Journal | October 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/mat.0000000000002873 | PMID 42821805 Get It

Challenging the Obesity Paradox: A Multicenter Study of Body Mass Index and Mortality in Venovenous Extracorporeal Membrane Oxygenation
Behaine, Juan J. Morales, Seelhammer, Troy G. , Wieruszewski, Patrick M., Liu, Emily, Schulte, Phillip J., Ursoleo, Jacopo D’Andria, Huelster, Joshua S., Prekker, Matthew E., Miller, William C., Ripoll, Juan G. , Morales Behaine, Juan J, Ripoll, Juan G , Brunsvold, Melissa E , Behaine, Juan Jose Morales , Wieruszewski, Patrick M. , Schulte, Phillip J. , Ursoleo, Jacopo D’Andria , Huelster, Joshua, Brunsvold, Melissa E.

Mayo Clinic

ASAIO Journal | August 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/mat.0000000000002819 | PMID 42617158 Get It

Obesity is common among critically ill adults, but its association with outcomes during venovenous extracorporeal membrane oxygenation (VV ECMO) remains controversial. We evaluated associations of body mass index (BMI) with mortality and Extracorporeal Life Support Organization (ELSO)–defined complications in adults supported with VV ECMO. We conducted a retrospective multicenter cohort study of adults receiving VV ECMO at four centers (2017–2025). The primary outcome was in-hospital mortality; secondary outcomes were ELSO-defined complications. Multivariable logistic regression was adjusted for age, sex, and hospital site; BMI was evaluated as continuous, dichotomized (≥30 vs . <30 kg/m 2 ), and World Health Organization (WHO) obesity class exposures, with interaction testing by coronavirus disease 2019 (COVID-19) status. Among 420 patients (median BMI, 31 kg/m 2 ), in-hospital mortality was 62%. Higher BMI was associated with mortality in non–COVID-19 acute respiratory distress syndrome (ARDS; odds ratio [OR] = 1.06 per 1 kg/m 2 , 95% confidence interval [CI] = 1.02–1.10, p = 0.003) but not in COVID-19 ARDS (OR = 1.00, 95% CI = 0.94–1.05); there was insufficient evidence of interaction between BMI and COVID-19 ( p = 0.07). Higher BMI was associated with renal complications in both groups and infectious complications in non–COVID-19 ARDS (OR = 1.05, 95% CI = 1.02–1.09, p = 0.003). No significant BMI × COVID-19 interaction was detected for any outcomes. These findings do not support an obesity survival paradox during VV ECMO.
Other surgical settings May Stand to benefit from pre-emptive mechanical circulatory support – Lessons Learned from cardiac surgery
Mariotti, Chiara , Bugo, Samuele , Ripoll, Juan G. , Ursoleo, Jacopo D’Andria , Wieruszewski, Patrick M , D'Andria Ursoleo, Jacopo , Wieruszewski, Patrick M.

Mayo Clinic

Perfusion | August 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/02676591261478497 | PMID 42608354 Get It

The conducting airways before and after gender‐affirming hormone therapy in transgender individuals
Kipp, Shalaya , Ramsook, Andrew H. , Miller, Alex J., Bustos, Samyd S., Martinez‐Jorge, Jorys, Welch, Brian T., Ripoll, Juan G., Miller, Alex J. , Joyner, Michael J , Ramsook, Andrew H , Kipp, Shalaya , Bustos, Samyd S. , Martinez‐Jorge, Jorys, Welch, Brian T. , Ripoll, Juan G. , Joyner, Michael J.

Mayo Clinic

Experimental Physiology | July 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1113/ep093927 | PMID 42446094 Get It

Abstract On average, females have smaller airways than males. The largest discrepancy in airway size occurs during puberty, when endogenous sex hormone concentrations diverge between males and females. Transgender individuals often use gender‐affirming hormone therapy (GAHT) to align physical characteristics with gender identity. It is unknown whether GAHT influences airway size (luminal area and length). We evaluated the large conducting airways before starting GAHT and while undergoing years of GAHT. This retrospective within‐subject study included 12 adult transgender individuals who underwent CT scanning before starting GAHT and again after ≥1 year of GAHT. For each transgender individual, we identified two matched cisgender controls (one male and one female) who also underwent two CT scans over a comparable time interval for longitudinal comparison. We used a three‐dimensional reconstruction of CT imaging to measure luminal areas. Within‐subject changes in airway size between scans were assessed using Student's paired t ‐tests in transgender individuals undergoing feminizing hormone therapy. Variance between scans was assessed using Levene's test. Pre‐scans occurred an average of 2.0 ± 3.1 years before beginning GAHT. Transgender persons were on GAHT for an average of 3.3 ± 1.7 years (range, 1.0 – 6.7 years) at their second scan. We found no significant differences in airway luminal cross‐sectional areas for transgender persons on feminizing hormone therapy. The variance in airway size change between scans was not statistically different between transgender individuals and control subjects. Our findings suggest that the size of large conducting airways might remain unchanged after a period (>1 year) on GAHT.
Safety of selective operating room extubation after median sternotomy for cardiac surgery with parasternal regional analgesia
Christensen, Jon M. , Ripoll, Juan G, Vinzant, Nathan J, Smith, Mark, Mauermann, William J, Dearani, Joseph A, Lemahieu, Allison M, Schroeder, Darrell R, Ritter, Matthew, Christensen, Jon , Ripoll, Juan G, Vinzant, Nathan J, Smith, Mark, Mauermann, William J, Dearani, Joseph A, Lemahieu, Allison M, Schroeder, Darrell R, Ritter, Matthew

Mayo Clinic

Regional Anesthesia & Pain Medicine | December 19, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-107157

10.1136/rapm-2025-107157 | PMID 41419242 Get It

Introduction The safety of operating room extubation (ORE) immediately following cardiac surgery via median sternotomy remains unclear. However, reported outcomes in the setting of parasternal regional analgesia are limited. This study examined the safety of ORE for patients who received postoperative superficial parasternal intercostal plane (SPIP) blocks following median sternotomy for cardiac surgery. Methods Single-center retrospective cohort study from January 2020 to September 2023 compared the outcomes of adult cardiac surgical patients who were either extubated in the operating room immediately after surgery with SPIP blocks (ORE-B), received SPIP blocks and were extubated in the intensive care unit within 6 hours (FTE-B) or did not receive SPIP blocks and were extubated in the intensive care unit within 6 hours (FTE). Assessed outcomes were reintubation, use of non-invasive positive pressure ventilation (NIPPV), intensive care unit (ICU) readmission, return to OR, postoperative transfusion, ICU and hospital length of stay. Results 2294 patients were studied, which included 256 ORE-B patients, 729 FTE-B patients and 1,309 FTE patients. Differences in reintubation rates (1.2% vs 0.7% vs 1.2%, all p≥0.26) and use of NIPPV (4.8% vs 4.8% vs 5.1%, all p≥0.743) did not differ between ORE-B, FTE-B, and FTE groups, respectively. Time to extubation differed between FTE-B and FTE groups (2.5 hours vs 3.8 hours, p=<0.001), respectively. Additionally, hospital length of stay was significantly shorter for groups ORE-B and FTE-B compared with group FTE (5 days vs 5 days vs 6 days), respectively. Conclusions Selective ORE after median sternotomy for cardiac surgery was not associated with an increased risk of reintubation and NIPPV use in the setting of parasternal regional analgesia.
Definitions for Vasoplegia Associated With On-Pump Cardiac Surgery: A Systematic Review With Meta-Analysis
Bauer, Seth R., Ripoll, Juan G. , Gerberi, Dana , Wieruszewski, Erin D. , Stephens, Elizabeth H. , Wittwer, Erica D. , Bauer, Seth R. , Wieruszewski, Patrick M , Bauer, Seth R , Wieruszewski, Patrick M. , Ortoleva, Jamel P. , Chatterjee, Subhasis , Joyner, Michael J.

Mayo Clinic

Critical Care Explorations | December 18, 2025 | Volume: 7 | Issue: 12 | Pages: e1361

10.1097/cce.0000000000001361 | PMID 41410546 Get It

OBJECTIVES: Vasoplegia is a common complication of cardiac surgery that uses cardiopulmonary bypass and contributes to morbidity and mortality, yet a consensus definition does not exist. The objective of this study was to evaluate the diagnostic criteria and definitions used to characterize vasoplegia and how different criteria influence incidence estimates. DATA SOURCES: Ovid Embase, Ovid MEDLINE, Scopus, Web of Science Core Collection, ClinicalTrials.gov, Ovid Cochrane Central Register of Controlled Trials, and the World Health Organization’s International Clinical Trials Registry Platform clinical trials registry. STUDY SELECTION: Randomized clinical trials and observational studies reporting on vasoplegia in adults undergoing any type of cardiac surgery that used cardiopulmonary bypass. DATA EXTRACTION: Proportional meta-analysis using a random-effects model and the inverse variance method was used to calculate the pooled incidence of vasoplegia and its clinical outcomes. DATA SYNTHESIS: A total of 68 studies encompassing 56,580 patients were identified, from which 63 unique vasoplegia definitions were used. Blood pressure ( n = 57 studies, 84%) and cardiac output ( n = 50 studies, 74%) were among the most common criteria used in vasoplegia definitions; however, there was a vast variety of threshold values applied within these criteria and all other criteria comprising the definitions. The pooled incidence of vasoplegia was 21% (95% CI, 17–25%), acute kidney injury was 32% (95% CI, 21–45%), and mortality was 12% (95% CI, 9–16%). Subgroup analysis revealed that transplantation and left ventricular assist device implantation surgeries, and those with baseline left ventricular ejection fraction less than 40% had a significantly greater incidence of vasoplegia. CONCLUSIONS: The published literature varies greatly in the criteria used to define vasoplegia associated with on-pump cardiac surgery. Generation and adoption of a unified definition for vasoplegia must be an international priority.
VV-ECMO as a lifesaving measure for refractory bronchospasm in anaphylactic shock: A case report
García-Méndez, Juan Pablo , Seelhammer, Troy G. , Wieruszewski, Patrick M. , Wittwer, Erica D. , Ripoll, Juan G. , Garcia-Mendez, Juan P , Wieruszewski, Patrick M

Mayo Clinic

Perfusion | September 29, 2025 | Volume: 41 | Issue: 6 | Pages: 1068-1071

10.1177/02676591251385891 | PMID 41021782 Get It

Refractory anaphylaxis is rare but carries high mortality, particularly when complicated by severe bronchospasm and respiratory failure. We present a 32-year-old individual with food-induced anaphylaxis and profound bronchospasm unresponsive to first- and second-line therapies, resulting in severe hypoxemic and hypercapnic respiratory failure despite mechanical ventilation. Peripheral venovenous extracorporeal membrane oxygenation (VV-ECMO) was emergently initiated, leading to rapid stabilization and full recovery. This case demonstrates the successful use of VV-ECMO as a life-saving bridge in anaphylaxis-induced respiratory failure. This is one of the few reported cases of successful use of VV-ECMO for refractory bronchospasm secondary to anaphylaxis.
Greater large conducting airway luminal area in adult patients with interstitial lung disease
Miller, Alex J. , Ovrom, Erik A. , Zaremba, Solomiia , Senefeld, Jonathon W. , Wiggins, Chad C. , Dominelli, Paolo B. , Ripoll, Juan G. , Welch, Brian T. , Ramsook, Andrew H. , Joyner, Michael J , Ramsook, Andrew H , Wiggins, Chad C , Senefeld, Jonathon W , Zaremba, Solomiia , Joyner, Michael J.

Mayo Clinic

Physiological Reports | September 24, 2025 | Volume: 13 | Issue: 18 | Pages: No page available

10.14814/phy2.70578 | PMID 40991235 Get It

AbstractInterstitial lung disease (ILD) encompasses pulmonary disorders characterized by chronic inflammation and fibrosis that disrupt pulmonary gas exchange. While ILD‐related changes in the lung parenchyma are well‐documented, less is known about how ILD affects luminal area within the large conducting airways. This retrospective, case–control study tested the hypothesis that patients with ILD would have greater large conducting airway luminal areas than healthy matched controls. Three‐dimensional reconstructions of computed tomography images were used to quantify airway luminal areas in patients with ILD (n = 82; 54% female) and healthy controls matched for age, sex, and height. Patients with ILD had 16%–22% greater airway luminal areas across all seven measured large conducting airways compared to controls (all p < 0.001). Among patients with ILD, males had 17%–34% greater height‐normalized airway luminal areas than females (all p < 0.05). These data provide evidence that ILD is associated with greater large conducting airway luminal area, even when matched for key demographic factors. Consistent with observations in health, males with ILD exhibited greater height‐normalized airway size than females. These findings offer new insight into airway remodeling in ILD and highlight potential sex differences in airway luminal area.
Case Report of Acute Respiratory Distress Syndrome After Photosensitive Bone Stabilization System Balloon Rupture: Unclear Etiology From Fat Embolism or Pulmonary Inflammation From Monomeric Resin
Howrigon, Annie B., Mauck, Karen F. , VanderWielen, Beth A. , Ripoll, Juan G. , Chen, James L. , Yuan, Brandon J. , Howrigon, Annie Bell

Mayo Clinic

A&A Practice | August 19, 2025 | Volume: 19 | Issue: 8 | Pages: e02030

10.1213/xaa.0000000000002030 | PMID 40827788 Get It

This case describes a 74-year-old woman who developed post-surgical acute respiratory distress syndrome (ARDS) after Photodynamic Bone Stabilization System (PBSS) a balloon rupture with extravasation of approximately 20 mL of monomeric resin. The ARDS likely resulted from 2 possibilities: (1) displacement of fat or tumor embolism from PBSS insertion/inflation, displacement from bioinert monomers, or orthopedic screws; or (2) chemical inflammation/pneumonitis due to intravascular dissemination of bioinert monomeric resin. Though balloon rupture and/or fat embolism is a stated manufacturer risk, (IlluminOss. Accessed May 19, 2025. https://illuminoss.com/uploads/nuggets/60e47f517ee33862a5fcaab8/900356_T.pdf) this is the first published human case report of ARDS as a complication of PBSS balloon rupture.